Ventures founded and first-author-led projects.
FOCUS — a portable surgical sterilizer
Airavata Bioengineering · founder & lead researcher · July 2025 – present
After family members in India died of hospital-acquired infections following surgery, I designed a portable sterilization device for rural surgical settings: an ellipsoidal reflector places a UV-C source at one focal point so reflected rays converge on the instrument tray — a shadow-free germicidal dose guaranteed by geometry. A 90-second cycle, no water, no consumables, no grid.
I ran the bench testing (multibacterial biofilm removal, UV coverage), wrote the funding applications, and filed the patents myself: four filings as sole inventor — two provisional, one utility, one PCT. The project has been offered $600K in venture funding and raised $21K in angel funding, won $15K in prizes (second place at the University of Utah's Bench-to-Bedside as a freshman against PhD-led teams; the Sorenson Impact Capital Prize, one of five teams on campus), and has been briefed to USAF, SOCOM, and the Defense Health Agency, with Air Force laboratory evaluation ongoing. I gave a sole-author podium presentation on FOCUS at the Utah Biomedical Engineering Conference in 2026.
Calibr Labs — a scalpel that knows what it's cutting
Co-founder · August 2025 – present
Smart surgical scalpels that classify tissue in real time from electrical impedance, force, and cutting angle — and, longer term, foundation models for the physical reality of cutting. We raised a $100K pre-seed at a $2M post-money valuation led by Convoi Ventures, placed top 15 in the YBV Venture Challenge, and have been invited to Y Combinator interviews in two consecutive batches, W26 and F26.
The company began as Insurabridge, an AI claims-and-appeals platform for under-resourced hospitals that I built full-stack and deployed into live clinical use across five clinics, before we pivoted to surgical sensing.
Predicting antibiotic resistance from the genome
Anahtar Lab, Massachusetts General Hospital / Harvard Medical School · September 2026 – present
Culture-based susceptibility testing takes days; patients with severe infections don't have days. At the Anahtar Lab I own an end-to-end project — the pipeline design, the models, the evaluation — to predict antibiotic resistance and rank likely-effective antibiotics for Pseudomonas aeruginosa directly from whole-genome sequences and susceptibility profiles of roughly 700 clinical infections. The design choices are the work: genomic feature representation, lineage-aware validation so models are scored on genuinely unseen strains, and a separate evaluation per antibiotic. It is the computational groundwork for resistance-aware diagnostics in the low-resource hospitals the rest of this page is about.
Wirelessly charging a pacemaker through human skin
Price College of Engineering, University of Utah · June 2024 – July 2025
An inductive power system that charged a dual-chamber pacemaker through a home-built skin phantom — silicone dermis over sponge tissue with a blood analog, standing in for $5,000 of cadaveric tissue — delivering two years of battery in under eight hours with a 0.3 °C tissue temperature rise. It won the Utah Science & Engineering Fair, took the Regeneron Biomedical Sciences Award at ISEF among ~1,800 global finalists, and led directly to my recruitment at Freyya as lead engineer for wireless power on a patented pelvic-floor biofeedback sensor slated for clinical trials in 2027.
Dorm Room Fund — Student Partner, Health × Bio
2026 – present
One of 60 student partners selected from more than 1,400 applicants — and the only one in the state of Utah — with full authority to write $40K–$250K checks into student-founded health and bio companies.